Innovating Works

UNHRO

MpoxVax AFRIVAC: Expanding a prospective clinical trial examining the immune response of participants receiving Modi... The current Mpox outbreak affecting the Democratic Republic of the Congo, ongoing since 2023, has resulted in more than 19,000 causes and ov...
2024-10-03 - 2027-03-31 | Financiado
Ebola PREP-TBOX: Development of a toolbox to improve preparedness strategies on surveillance in human animal interfac... UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2023-01 The recent outbreak of Ebola virus (EBOV), in particular the EBOV Sudan strain, is a major cause for concern as there are currently no avail...
2024-09-26 - 2027-09-30 | Financiado
DECIPHER-MPOX: Deciphering host genetics and viral determinants of MPOX epidemiology in the Democratic Republic of... Background: Monkeypox virus (MPV) is a member of the Poxviridae family that includes smallpox, cowpox and chickenpox viruses. Endemic to equ...
2024-08-09 - 2026-07-31 | Financiado
SECRET: Supporting Research Ethics Committees for efficient functionality and national accreditation to REvi... BACKGROUND There are few research ethics committees (RECs) with capacity to review and provide oversight for clinical trials in Sub-Saharan...
2024-06-03 - 2027-06-30 | Financiado
MOBILE MEN: Implementing oral and long acting Pre exposure prophylaxis in mobile men in Sub Saharan Africa MOB... UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 Reducing HIV is key 2030 SDG target. In Africa, HIV prevention research has focused on young women yet heterosexual men, vulnerable due to t...
2023-06-22 - 2026-06-30 | Financiado
GREAT-LIFE: Linking Infectious disease Front-liners’ control Efforts with central public health authorities in T... UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 The African Great Lakes region is one of the most densely populated areas in Africa and also one of the areas globally with the highest biod...
2023-06-13 - 2028-06-30 | Financiado
ACCESSAFRICA2: Strengthening Clinical Trial Regulatory and Ethical review Oversight in East Africa UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un HORIZON EUROPE: HORIZON-JU-GH-EDCTP3-2022-01 There is an increase in the number of drug development clinical trials conducted in Sub-Saharan Africa (SSA), including vaccine development...
2023-04-28 - 2026-06-30 | Financiado
DI-DIDA: Digital Innovations and Diagnostics for Infectious Diseases in Africa UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 The DI-DIDA project's overall objective is to tackle poverty-related infectious diseases in sub-Saharan Africa and African islands by i) str...
2022-08-17 - 2027-09-30 | Financiado
EHVA: European HIV Vaccine Alliance EHVA a EU platform for the discovery and evaluation of novel prophy... UGANDA NATIONAL HEALTH RESEARCH ORGANISATION participó en un H2020: H2020-PHC-2014-2015 Many HIV vaccine concepts and several efficacy trials have been conducted in the prophylactic and therapeutic fields with limited success. T...
2015-12-17 - 2023-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.